Treatment Implications for Men When Switching From Male toFemale Bone Mineral Density Reference Data: The Manitoba Bone Density Program

Journal of Clinical Densitometry

Volumn 16, Issue 4, 2013, Pages 537-542

  Leslie, William D ^a   Majumdar, Sumit R ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Absolute risk; Dual energy x ray absorptiometry; FRAX; Men; Osteoporosis

Indexed keywords

ADULT; AGED; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; BONE DENSITOMETRY; BONE DENSITY; BONE MASS; CANADA; CONTROLLED STUDY; DENSITOMETER; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK FRACTURE; FRAGILITY FRACTURE; HEALTH SURVEY; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NATIONAL OSTEOPOROSIS FOUNDATION GUIDELINE; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; SPINE FRACTURE; TREATMENT INDICATION;

ABSOLUTE RISK; DUAL-ENERGY X-RAY ABSORPTIOMETRY; FRAX; MEN; OSTEOPOROSIS;

ABSORPTIOMETRY, PHOTON; AGED; AGED, 80 AND OVER; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; CALCIUM, DIETARY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MANITOBA; MIDDLE AGED; OSTEOPOROTIC FRACTURES; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; RISK ASSESSMENT; TREATMENT OUTCOME; VITAMIN D;

EID: 84887017628     PISSN: 10946950     EISSN: 15590747     Source Type: Journal    
DOI: 10.1016/j.jocd.2013.07.004     Document Type: Article

References (30)

1. Kanis J.A., Melton L.J., Christiansen C., et al. The diagnosis of osteoporosis. J Bone Miner Res 1994, 9:1137-1141.
2. Kanis J.A., McCloskey E.V., Johansson H., et al. A reference standard for the description of osteoporosis. Bone 2008, 42:467-475.
3. Ebeling P.R. Clinical practice. Osteoporosis in men. N Engl J Med 2008, 358:1474-1482.
4. Watts N.B., Adler R.A., Bilezikian J.P., et al. Osteoporosis in men: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2012, 97:1802-1822.
5. Kanis J.A., Bianchi G., Bilezikian J.P., et al. Towards a diagnostic and therapeutic consensus in male osteoporosis. Osteoporos Int 2011, 22:2789-2798.
6. Binkley N.C., Schmeer P., Wasnich R.D., Lenchik L. What are the criteria by which a densitometric diagnosis of osteoporosis can be made in males and non-Caucasians?. J Clin Densitom 2002, 5(Suppl):S19-S28.
7. De Laet C.E., van der K.M., Hofman A., Pols H.A. Osteoporosis in men and women: a story about bone mineral density thresholds and hip fracture risk. J Bone Miner Res 2002, 17:2231-2236.
8. Langsetmo L., Leslie W.D., Zhou W., et al. Using the same bone density reference database for men and women provides a simpler estimation of fracture risk. J Bone Miner Res 2010, 25:2108-2114.
9. Cranney A., Jamal S.A., Tsang J.F., et al. Low bone mineral density and fracture burden in postmenopausal women. CMAJ 2007, 177:575-580.
10. Siris E.S., Chen Y.T., Abbott T.A., et al. Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med 2004, 164:1108-1112.
11. Stone K.L., Seeley D.G., Lui L.Y., et al. BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res 2003, 18:1947-1954.
12. Kanis J.A., Oden A., Johnell O., et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 2007, 18:1033-1046.
13. Kanis J.A., Oden A., Johansson H., et al. FRAX and its applications to clinical practice. Bone 2009, 44:734-743.
14. Kanis J.A., Barton I.P., Johnell O. Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture. Osteoporos Int 2005, 16:475-482.
15. Lyles K.W., Colon-Emeric C.S., Magaziner J.S., et al. Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 2007, 357:1799-1809.
16. National Osteoporosis Foundation Clinician's guide to prevention and treatment of osteoporosis 2013, National Osteoporosis Foundation, Washington, DC.
17. Kiebzak G.M., Beinart G.A., Perser K., et al. Undertreatment of osteoporosis in men with hip fracture. Arch Intern Med 2002, 162:2217-2222.
18. Leslie W.D., LaBine L., Klassen P., et al. Closing the gap in postfracture care at the population level: a randomized controlled trial. CMAJ 2012, 184:290-296.
19. Leslie W.D., MacWilliam L., Lix L., et al. A population-based study of osteoporosis testing and treatment following introduction of a new bone densitometry service. Osteoporos Int 2005, 16:773-782.
20. Leslie W.D., Caetano P.A., MacWilliam L.R., Finlayson G.S. Construction and validation of a population-based bone densitometry database. J Clin Densitom 2005, 8:25-30.
21. Lix L.M., Azimaee M., Osman B.A., et al. Osteoporosis-related fracture case definitions for population-based administrative data. BMC Public Health 2012, 12:301.
22. Fraser L.A., Langsetmo L., Berger C., et al. Fracture prediction and calibration of a Canadian FRAX(R) tool: a population-based report from CaMos. Osteoporos Int 2011, 22:829-837.
23. Dawson-Hughes B., Looker A.C., Tosteson A.N., et al. The potential impact of the National Osteoporosis Foundation guidance on treatment eligibility in the USA: an update in NHANES 2005-2008. Osteoporos Int 2012, 23:811-820.
24. Ettinger B., Black D.M., Dawson-Hughes B., et al. Updated fracture incidence rates for the US version of FRAX. Osteoporos Int 2010, 21:25-33.
25. Leslie W.D., Lix L.M., Langsetmo L., et al. Construction of a FRAX((R)) model for the assessment of fracture probability in Canada and implications for treatment. Osteoporos Int 2011, 22:817-827.
26. Leslie W.D., Lix L.M., Johansson H., et al. Independent clinical validation of a Canadian FRAX tool: fracture prediction and model calibration. J Bone Miner Res 2010, 25:2350-2358.
27. Lewiecki E.M., Kendler D.L., Kiebzak G.M., et al. Special report on the official positions of the International Society for Clinical Densitometry. Osteoporos Int 2004, 15:779-784.
28. Melton L.J., Atkinson E.J., O'Connor M.K., et al. Bone density and fracture risk in men. J Bone Miner Res 1998, 13:1915-1923.
29. Papaioannou A., Morin S., Cheung A.M., et al. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ 2010, 182:1864-1873.
30. Lentle B., Cheung A.M., Hanley D.A., et al. Osteoporosis Canada 2010 guidelines for the assessment of fracture risk. Can Assoc Radiol J 2011, 62:243-250.